Legend Biotech Corp (LEGN) — Financial Flexibility Index
Legend Biotech Corp (LEGN) has a Financial Flexibility Index of -0.09x as of March 2026. Free cash flow of $-59.38 Million (operating CF $-85.35 Million minus capex $25.98 Million) represents 0% of total liabilities ($629.02 Million). Check LEGN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Legend Biotech Corp Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Legend Biotech Corp across 9 annual periods. See working capital position of Legend Biotech Corp to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Legend Biotech Corp (2017–2025)
Year-by-year free cash flow to debt coverage for Legend Biotech Corp. For the full company profile including market capitalisation, see Legend Biotech Corp market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.04x | $-32.89 Million | $-100.47 Million | $731.60 Million | ▲ +78.2% |
| 2024 | -0.21x | $-129.93 Million | $-144.03 Million | $629.61 Million | ▲ +66.7% |
| 2023 | -0.62x | $-370.55 Million | $-393.28 Million | $597.24 Million | ▼ -103.3% |
| 2022 | -0.31x | $-179.01 Million | $-201.28 Million | $586.65 Million | ▲ +29.5% |
| 2021 | -0.43x | $-153.06 Million | $-198.47 Million | $353.52 Million | ▲ +72.5% |
| 2020 | -1.58x | $-192.72 Million | $-223.00 Million | $122.27 Million | ▼ -1374.3% |
| 2019 | -0.11x | $-43.90 Million | $-83.06 Million | $410.58 Million | ▼ -113.7% |
| 2018 | 0.78x | $328.70 Million | $307.68 Million | $420.40 Million | ▲ +11995.0% |
| 2017 | -0.01x | $-1.49 Million | $-2.38 Million | $226.53 Million | — |